FDA

New FDA Labeling Requirements Highlight Risks of Opioid Pain Medications

New FDA Labeling Requirements Highlight Risks of Opioid Pain Medications

The U.S. Food and Drug Administration is requiring safety labeling changes to all opioid pain medications to better emphasize and explain the risks associated with their long-term use. These changes follow a public advisory committee meeting in May that reviewed data showing serious risks—such as misuse, addiction, and both fatal and non-fatal overdoses—for patients...

FDA Approval Expands Vonvendi Use for Children and Adults With von Willebrand Disease

FDA Approval Expands Vonvendi Use for Children and Adults With von Willebrand Disease

The U.S. Food and Drug Administration recently approved expanded use of Vonvendi [von Willebrand factor (Recombinant)] for routine preventative (prophylactic) use in adults (age 18 years and older) with all types of von Willebrand disease (VWD) and on-demand and treatment of bleeding episodes and perioperative use in children with VWD. Previously, Vonvendi was...

A Breakthrough for Rare Disease: FDA Accelerates Approval of First Barth Syndrome Treatment

A Breakthrough for Rare Disease: FDA Accelerates Approval of First Barth Syndrome Treatment

The U.S. Food and Drug Administration recently granted accelerated approval to Forzinity (elamipretide) injection as the first treatment for Barth syndrome, in patients weighing at least 30 kg. Barth syndrome is a rare, serious and life-threatening disease of the mitochondria (the energy-producing parts of cells). “The FDA remains committed to facilitating the...

A Vision Breakthrough: FDA Authorizes First Eyeglass Lenses to Slow Pediatric Myopia

A Vision Breakthrough: FDA Authorizes First Eyeglass Lenses to Slow Pediatric Myopia

The U.S. Food and Drug Administration recently authorized marketing of the Essilor Stellest eyeglass lenses to correct myopia, commonly referred to as nearsightedness, with or without astigmatism and to slow the progression of the disease in children 6 to 12 years old at the initiation of treatment. Strengthening the foundation of our nation’s health begins at...

Microneedling Explained: Benefits, Risks, and How to Stay Safe

Microneedling Explained: Benefits, Risks, and How to Stay Safe

Being pricked by tiny needles may sound like a strange way to make your skin look better, but that’s the concept behind a skin care technique called microneedling. People are using microneedling in a variety of ways from reducing scarring, to treating fine lines and wrinkles. It is important to be aware of the risks as well as benefits associated with microneedling...

FDA Issues New Safety Warning and Limits Use of Elevidys Following Fatal Liver Injury Reports

FDA Issues New Safety Warning and Limits Use of Elevidys Following Fatal Liver Injury Reports

The U.S. Food and Drug Administration recently announced it is taking action to approve new labeling submitted by the company that includes the addition of a Boxed Warning, the agency’s most prominent safety warning, to Elevidys (delandistrogene moxeparvovec-rokl), and that the indication section of the labeling limits the therapy’s indication to ambulatory patients...